Lombard Odier Asset Management (Switzerland)’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
BPC
PHS
CS
GE
PVI
PAMS
Lombard Odier Asset Management (Switzerland)'s SOPH Position: Q1 2022 in Review
Lombard Odier Asset Management (Switzerland) sold out of SOPHiA GENETICS (SOPH) in Q1 2022, closing a stake of 146,844 shares — an estimated $2.07M sold.
Lombard Odier Asset Management (Switzerland) first reported a position in SOPH in Q3 2021 and held it in 2 quarters. The position peaked at $2.55M in Q3 2021. 29 funds tracked by Wall St. Rank hold SOPH as of Q1 2022.
- Lombard Odier Asset Management (Switzerland) reported no remaining SOPHiA GENETICS position as of Q1 2022 after selling out during the quarter.
- Lombard Odier Asset Management (Switzerland) sold 146,844 SOPHiA GENETICS shares in Q1 2022, an estimated $2.07M.
- Lombard Odier Asset Management (Switzerland) first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 2 quarters.
- Lombard Odier Asset Management (Switzerland)'s SOPHiA GENETICS position peaked at $2.55M in Q3 2021.
- 29 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2022.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2022, filed 16 May 2022.